NCT07015827

Brief Summary

This randomized trial aims to assess the glycemic index (GI) of locally available mango varieties in healthy adult participants, using glucose as the reference food. The study will evaluate the postprandial blood glucose response elicited by selected mango varieties and compare it to the response produced by a standard glucose . The objective is to determine whether certain mango varieties have a lower glycemic impact, which may be relevant for dietary planning and public health recommendations.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2025

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

2 months

First QC Date

June 3, 2025

Last Update Submit

June 3, 2025

Conditions

Keywords

Glycemic indexposprandial glucose responseglycemic load

Outcome Measures

Primary Outcomes (1)

  • Glycemic Index (GI) of Mango Varieties

    Glycemic index will be calculated for each mango variety by measuring the postprandial blood glucose response over 120 minutes and comparing the incremental area under the curve (iAUC) to that of a standard glucose reference.

    0 to 120 minutes after consumption of test food

Secondary Outcomes (1)

  • Peak Blood Glucose Level

    0 to 120 minutes after consumption

Study Arms (1)

Single group (cross over)

ACTIVE COMPARATOR

Participants will consume 50 grams of glucose solution. This serves as the reference food for calculating the glycemic index

Other: Mango (langra)Other: mango (chaunsa)Other: MANGO (SINDHRI)

Interventions

Participants will consume mango variety A . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.

Single group (cross over)

Participants will consume mango variety B . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.

Single group (cross over)

Participants will consume mango variety C . The test food will provide 50 grams of available carbohydrates, and will be consumed after an overnight fast.

Single group (cross over)

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy non-diabetic adults
  • Normal fasting blood glucose levels
  • Willingness to provide informed consent

You may not qualify if:

  • Diagnosis of diabetes mellitus or impaired glucose tolerance
  • Gastrointestinal, metabolic, or endocrine disorders
  • Current use of medications affecting blood glucose
  • Pregnant or lactating women
  • Smoking or alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Mangifera indica extract

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate proffessor

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

June 1, 2025

Primary Completion

August 1, 2025

Study Completion

September 1, 2025

Last Updated

June 11, 2025

Record last verified: 2025-06